Related Experiment Video
Updated: Jan 24, 2026

Identification of protein complexes with quantitative proteomics in S. cerevisiae
Published on: March 4, 2009
Quantitative Interactome Proteomics Reveals a Molecular Basis for ATF6-Dependent Regulation of a Destabilized
Lars Plate1, Bibiana Rius2, Bianca Nguyen2
1Department of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, MB110, La Jolla, CA 92037, USA; Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Abstract:
Activation of the unfolded protein response (UPR)-associated transcription factor ATF6 has emerged as a promising strategy to reduce the secretion and subsequent toxic aggregation of destabilized, amyloidogenic proteins implicated in systemic amyloid diseases. However, the molecular mechanism by which ATF6 activation reduces the secretion of amyloidogenic proteins remains poorly defined. We employ a quantitative interactomics platform to define how ATF6 activation reduces secretion of a destabilized, amyloidogenic immunoglobulin light chain (LC) associated with light-chain amyloidosis (AL). Using this platform, we show that ATF6 activation increases the targeting of this destabilized LC to a subset of pro-folding ER proteostasis factors that retains the amyloidogenic LC within the ER, preventing its secretion. Our results define a molecular basis for the ATF6-dependent reduction in destabilized LC secretion and highlight the advantage for targeting this UPR-associated transcription factor to reduce secretion of destabilized, amyloidogenic proteins implicated in AL and related systemic amyloid diseases.
Insights
Activating the unfolded protein response (UPR) transcription factor ATF6 prevents toxic amyloid protein secretion by targeting it to ER proteostasis factors. This mechanism reduces amyloidogenic protein aggregation in systemic amyloid diseases.
Area of Science:
- Cellular biology
- Molecular medicine
- Protein biochemistry
Background:
- Systemic amyloid diseases involve toxic aggregation of amyloidogenic proteins.
- Activation of the unfolded protein response (UPR) transcription factor ATF6 is a potential therapeutic strategy.
- The precise mechanism by which ATF6 reduces amyloidogenic protein secretion is not well understood.
Purpose of the Study:
- To elucidate the molecular mechanism by which ATF6 activation reduces the secretion of destabilized, amyloidogenic immunoglobulin light chains (LCs).
- To investigate the role of ER proteostasis factors in ATF6-mediated reduction of LC secretion.
Main Methods:
- Utilized a quantitative interactomics platform to analyze protein interactions.
- Studied the effect of ATF6 activation on the targeting of destabilized LCs in the endoplasmic reticulum (ER).
Main Results:
- ATF6 activation enhances the targeting of destabilized LCs to specific ER proteostasis factors.
- This increased targeting retains amyloidogenic LCs within the ER, inhibiting their secretion.
- Defined a molecular basis for ATF6-dependent reduction of destabilized LC secretion.
Conclusions:
- ATF6 activation provides a mechanism to reduce the secretion of destabilized, amyloidogenic proteins.
- Targeting ATF6 is a promising strategy for treating light-chain amyloidosis (AL) and related systemic amyloid diseases.
- The findings highlight the importance of ER proteostasis in managing amyloidogenic protein disorders.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Covalently Linked Protein Regulators
Molecular Chaperones and Protein Folding
The...
Destabilization of Microtubules

